gold has been researched along with Kidney Diseases in 92 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 66 (71.74) | 18.7374 |
1990's | 7 (7.61) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 10 (10.87) | 24.3611 |
2020's | 9 (9.78) | 2.80 |
Authors | Studies |
---|---|
Chen, X; Chu, B; Feng, S; He, Q; He, Y; Huang, Z; Li, P; Lin, T; Qian, Z; Qu, Y; Wang, P; Yang, Z | 1 |
Abbasi, BH; Anjum, I; Anjum, S; Bukhari, S; Hano, C; Hashim, M; Hassan, S; Mujahid, H | 1 |
Cho, M; Kim, JK; Lee, K; Lee, S; Oh, J; Paulson, B | 1 |
Jaiwal, R; Kamboj, M; Kumar, P; Pundir, CS | 1 |
Gao, H; Jia, Y; Li, J; Qi, J; Tian, J; Yu, BY; Yu, XA | 1 |
Beard, P; Comenge, J; David, AL; Kalber, TL; Lythgoe, MF; Ogunlade, O; Patrick, PS; Stuckey, DJ; Zaw Thin, M | 1 |
Cai, W; Huang, P; Jiang, D; Lin, J; Ni, D; Rosenkrans, ZT | 1 |
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
Geng, X; Hu, J; Lai, X; Tan, L; Wang, S | 1 |
Choo, MS; Joung, Y; Jue, M; Kim, JK; Lee, S; Namgoong, JM; Ryu, CM; Shin, DM | 1 |
Chen, H; Chen, M; Liu, J; Tan, Y; Wu, J | 1 |
Afrifa, J; Dankyira, DO; Ephraim, RKD; Essien-Baidoo, S; Nkrumah, D | 1 |
Li, C; Ning, F; Pan, W; Peng, W; Wang, Y; Xie, W; Xin, H; Zhang, J; Zhang, X; Zhang, Y | 1 |
Yu, M | 1 |
Abdelhalim, MAK; Al-Ayed, MS; Al-Mohy, Y; Qaid, HA | 1 |
Deng, X; Geng, X; Hu, J; Lai, X; Li, A; Li, J; Liu, Y; Qiu, M; Tan, L; Yu, M; Zeng, T; Zhang, M; Zhou, G | 1 |
Abassi, Z; Abu-Saleh, N; Amal, H; Awad, H; Gharra, A; Haick, H; Jeries, R; Nakhleh, MK | 1 |
Al-Quraishy, S; Bauomy, AA; Diab, MS; Dkhil, MA; Khalil, MF | 1 |
Jaswal, A; Reshi, MS; Shrivastava, S; Shukla, S; Sinha, N; Uthra, C | 1 |
DETER, RL; LIEBELT, RA | 1 |
DIMITRIU, CG; NESTOR, R; TIEGERMAN, T | 1 |
ETCHART, M; PUGA, F; RIVAS, F | 1 |
MAHER, JF; SCHREINER, GE | 1 |
Sigler, JW | 1 |
Davis, P | 1 |
Antonovych, TT | 1 |
Maher, JF | 1 |
Druet, P; Fillastre, JP; Méry, JP | 1 |
Dumler, F | 1 |
Khan, AH; Nagi, AH | 1 |
Koshikawa, S; Sato, M | 1 |
Shaw, CF | 1 |
Sugihara, H | 1 |
Chiba, S; Eto, S; Kaizu, K; Maruoka, K; Oda, E; Oda, S; Okazaki, I; Ono, A; Suzuki, H | 1 |
Gärtner, HV | 1 |
Iesato, K; Inoue, S; Matsui, N; Mori, Y; Okuda, K; Ueda, S; Wakashin, M; Wakashin, Y | 1 |
Reidenberg, MM | 1 |
Billingsley, LM; Stevens, MB | 1 |
O'Brien, WM | 1 |
Erickson, SB | 1 |
Wakashin, M; Wakashin, Y | 1 |
Bruno, M; Cosseddu, D; Linari, F; Manganaro, M; Pellerito, R; Ravarino, N; Torchio, B; Urbano, D | 1 |
Bigazzi, PE | 1 |
Payne, BJ; Saunders, LZ | 2 |
Arena, E; Payne, BJ | 1 |
Cervi, G; Colamussi, V; Scaramelli, M; Trotta, F | 1 |
Ehrlich, GE; Gordon, MH; Tiger, LH | 1 |
Fossati, C | 1 |
Kazantzis, G | 1 |
Goyer, RA | 1 |
Kunin, CM; Proctor, RA | 1 |
Peklina, GP | 1 |
Engleman, EP; Hopper, J; Lee, JC; Samuels, B | 1 |
Hall, TA; Makin, M; Peters, PD; Robin, GC; Stein, H; Yarom, R | 1 |
Helm, E | 1 |
Dohi, K; Morita, H | 1 |
Aparicio, SR; Davison, AM; Goode, NP; Shires, M | 1 |
Gallo, GR; Yang, GC | 1 |
Inomata, A; Kikuchi, M; Maruyama, Y; Nakano, M; Nishi, S; Ogino, S; Ozawa, T; Satoh, H; Satoh, T; Suzuki, S | 1 |
Hall, CL | 2 |
Hall, CL; Tighe, R | 1 |
Hill, GS | 1 |
Davin, JC; Franchimont, P; Mahieu, PR; Malaise, MG | 1 |
Capell, HA; Hunter, JA | 1 |
Adler, SG; Border, WA; Cohen, AH | 1 |
Fioravanti, A; Frati, E; Giordano, N; Marcolongo, R; Morozzi, G; Taddeo, A | 1 |
Hirota, T; Kamitsuji, H; Kusumoto, K; Nakajima, M; Taira, K | 1 |
Watanabe, IS; Watanabe, M | 1 |
Smith, PS | 1 |
Kirchheiner, B; Rasmussen, GG | 1 |
Huriet, C | 1 |
Anttila, R; Laaksonen, AL | 1 |
Hayashi, Y; Igarashi, M; Masuda, M; Okitsu, K; Yoshino, S | 1 |
Rovenský, J; Trnavský, K | 1 |
Leblanc, A; Vernet, A | 1 |
Burry, HC | 2 |
Anttila, R; Koskiahde, V; Laaksonen, AL; Mäkinen, E; Rönning, O | 1 |
Hart, FD | 1 |
Scheiffarth, F | 1 |
Alexander, F; Barabas, AZ; Nagi, AH | 1 |
Gigante, D | 1 |
Galle, P; Stuve, J | 1 |
Fernandez-Herlihy, L | 1 |
Hándlová, D | 2 |
Meyer, W | 1 |
Altman, A; Dardik, H; Dardik, I; Podolsky, S | 1 |
21 review(s) available for gold and Kidney Diseases
Article | Year |
---|---|
Implication of Nanoparticles to Combat Chronic Liver and Kidney Diseases: Progress and Perspectives.
Topics: Anti-Inflammatory Agents; Antioxidants; Cyclooxygenase 2; Cytokines; Gold; Humans; Kidney Diseases; Liver; Metal Nanoparticles; Nanoparticles; Oxidative Stress; Reactive Oxygen Species; Silver; Zinc Oxide | 2022 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
GOLDTHIOGLUCOSE AS AN EXPERIMENTAL TOOL.
Topics: Carcinogens; Fatty Liver; Gold; Hypothalamus; Kidney Diseases; Obesity; Pancreas; Pathology; Peptic Ulcer; Research; Toxicology | 1964 |
TOXIC NEPHROPATHY.
Topics: Analgesics; Analgesics, Non-Narcotic; Anti-Bacterial Agents; Antipyretics; Arsenic; Bismuth; Cadmium; Carbon Tetrachloride Poisoning; Contrast Media; Glycols; Gold; Heat Exhaustion; Insecticides; Kidney Diseases; Lead Poisoning; Mercury Poisoning; Metals; Poisoning; Radiation Injuries; Salicylates; Sulfonamides; Toxicology; Uranium; Venoms | 1965 |
Auranofin.
Topics: Animals; Anti-Inflammatory Agents; Antibody Formation; Arthritis, Rheumatoid; Auranofin; Aurothioglucose; Clinical Trials as Topic; Diarrhea; Drug Eruptions; Gold; Gold Sodium Thiomalate; Hematologic Diseases; Humans; Immunity, Cellular; Kidney Diseases; Leukocytes; Neutrophils; Nucleic Acids | 1984 |
Drug-induced nephropathies.
Topics: Allopurinol; Aminoglycosides; Analgesics; Anti-Bacterial Agents; Anti-Inflammatory Agents; Captopril; Cephalosporins; Cisplatin; Diuretics; Glomerulonephritis; Gold; Humans; Kidney; Kidney Diseases; Kidney Tubular Necrosis, Acute; Lithium; Nephritis, Interstitial; Penicillamine; Penicillins; Rifampin; Semustine; Sulfonamides; Tetracycline; Trimethadione | 1984 |
Clinicopathologic spectrum of drug nephrotoxicity.
Topics: Aminoglycosides; Analgesics; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antineoplastic Agents; Captopril; Cimetidine; Contrast Media; Cyclosporins; Drug-Related Side Effects and Adverse Reactions; Glomerulonephritis; Gold; Humans; Ischemia; Kidney; Kidney Diseases; Kidney Diseases, Cystic; Kidney Papillary Necrosis; Kidney Tubular Necrosis, Acute; Lithium; Nephrotic Syndrome; Toxins, Biological | 1984 |
[Drug-induced glomerular nephropathies].
Topics: Animals; Anti-Inflammatory Agents; Anticonvulsants; Daunorubicin; Disease Models, Animal; Doxorubicin; Drug-Related Side Effects and Adverse Reactions; Gold; Humans; Kidney Diseases; Kidney Glomerulus; Lithium; Mercury; Mitomycin; Mitomycins; Rats; Rats, Inbred Strains; Sulfhydryl Compounds | 1983 |
The biochemistry and subcellular distribution of gold in kidney tissue: implications for chrysotherapy and nephrotoxicity.
Topics: Animals; Cell Nucleus; Cytosol; Gold; Gold Sodium Thiomalate; Kidney; Kidney Diseases; Mitochondria; Protein Binding; Rats; Subcellular Fractions | 1981 |
Environmental factors in renal disease.
Topics: Acetaminophen; Anti-Inflammatory Agents; Cadmium Poisoning; Cisplatin; Environmental Exposure; Gold; Humans; Hydrocarbons; Kidney Diseases; Mercury; Metals; Suicide | 1981 |
[Kidney disorders induced by non-steroidal anti-inflammatory agents and immunomodulators].
Topics: Adjuvants, Immunologic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Autoimmunity; Cyclosporine; Gold; Humans; Kidney Diseases; Phenacetin | 1994 |
[Renal damage in rheumatoid arthritis].
Topics: Adult; Amyloidosis; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cyclosporine; Female; Glomerulonephritis; Gold; Humans; Kidney Diseases; Kidney Failure, Chronic; Male; Methotrexate; Middle Aged; Penicillamine; Vasculitis | 1994 |
Metals and kidney autoimmunity.
Topics: Animals; Autoimmune Diseases; Autoimmunity; Disease Models, Animal; Environmental Health; Gold; Humans; Kidney; Kidney Diseases; Mercury; Metals; Mice; Rabbits; Rats | 1999 |
Heavy metal nephropathy of rodents.
Topics: Adenoma; Animals; Cadmium; Female; Gold; Gold Sodium Thiomalate; Kidney; Kidney Diseases; Kidney Neoplasms; Lead Poisoning; Male; Mercury Poisoning; Metals; Mice; Nephrosclerosis; Rats; Rodent Diseases | 1978 |
[Side-effects and toxic effects of gold salts].
Topics: Arthritis, Rheumatoid; Chemical and Drug Induced Liver Injury; Drug Eruptions; Drug Hypersensitivity; Eosinophilia; Gastrointestinal Diseases; Gold; Hematologic Diseases; Hemorrhagic Disorders; Humans; Kidney Diseases; Respiratory Tract Diseases | 1979 |
Effect of toxic, chemical, and environmental factors on the kidney.
Topics: Anti-Bacterial Agents; Bismuth; Cadmium Poisoning; Contrast Media; Environmental Exposure; Gold; Humans; Kidney; Kidney Diseases; Lead Poisoning; Mercury Poisoning; Occupational Diseases; Radiation Injuries | 1979 |
Hypersensitivity phenomena and the kidney: role of drugs and environmental agents.
Topics: Animals; Anti-Glomerular Basement Membrane Disease; Anti-Inflammatory Agents; Antibodies; Captopril; Drug Hypersensitivity; Environmental Exposure; Glomerulonephritis; Gold; Heroin; Humans; Hydrocarbons; Hypersensitivity, Delayed; Hypersensitivity, Immediate; Immune Complex Diseases; Kidney Diseases; Kidney Glomerulus; Lupus Erythematosus, Systemic; Mercury; Nephritis, Interstitial; Penicillamine; Penicillins; Rifampin | 1985 |
Pathology of gold nephropathy: a review.
Topics: Arthritis, Rheumatoid; Gold; Humans; Kidney; Kidney Diseases | 1987 |
Rheumatoid arthritis: extra-articular manifestations.
Topics: Arthritis, Rheumatoid; Edema; Female; Forearm; Gastrointestinal Diseases; Gold; Hand; Humans; Kidney Diseases; Lung Diseases; Lymphadenitis; Male; Nervous System Diseases; Phenacetin; Rheumatic Heart Disease; Skin Diseases; Uveitis; Vascular Diseases | 1969 |
Renal disorders in rheumatoid arthritis.
Topics: Acetaminophen; Adrenal Cortex Hormones; Amyloidosis; Arthritis, Rheumatoid; Bacteriuria; Biopsy; Endarteritis; Glomerular Filtration Rate; Glomerulonephritis; Gold; Humans; Hyperplasia; Kidney; Kidney Diseases; Nephritis, Interstitial | 1971 |
[Immunosuppressive treatment and its side effects].
Topics: Adrenal Cortex Hormones; Animals; Antilymphocyte Serum; Antineoplastic Agents; Autoimmune Diseases; Chromosomes; Cryosurgery; Female; Gold; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Infections; Kidney Diseases; Lymphocyte Activation; Mononuclear Phagocyte System; Mycoses; Neoplasms; Pregnancy; Pregnancy Complications; Prognosis; Transplantation; Transplantation Immunology; Vaccination; Virus Diseases | 1971 |
2 trial(s) available for gold and Kidney Diseases
Article | Year |
---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Auranofin.
Topics: Animals; Anti-Inflammatory Agents; Antibody Formation; Arthritis, Rheumatoid; Auranofin; Aurothioglucose; Clinical Trials as Topic; Diarrhea; Drug Eruptions; Gold; Gold Sodium Thiomalate; Hematologic Diseases; Humans; Immunity, Cellular; Kidney Diseases; Leukocytes; Neutrophils; Nucleic Acids | 1984 |
71 other study(ies) available for gold and Kidney Diseases
Article | Year |
---|---|
Novel gold-platinum nanoparticles serve as broad-spectrum antioxidants for attenuating ischemia reperfusion injury of the kidney.
Topics: Antioxidants; Catalase; Cytokines; Fibrosis; Gold; Humans; Inflammasomes; Kidney; Kidney Diseases; Metal Nanoparticles; Oxidative Stress; Platinum; Reactive Oxygen Species; Reperfusion Injury | 2022 |
Diagnosis of Ischemic Renal Failure Using Surface-Enhanced Raman Spectroscopy and a Machine Learning Algorithm.
Topics: Algorithms; Animals; Biomarkers; Gold; Kidney Diseases; Rats; Renal Insufficiency; Spectrum Analysis, Raman | 2022 |
Fabrication of an improved amperometric creatinine biosensor based on enzymes nanoparticles bound to Au electrode.
Topics: Amidohydrolases; Biosensing Techniques; Creatinine; Electrodes; Gold; Humans; Kidney Diseases; Limit of Detection; Muscular Diseases; Nanoparticles; Sarcosine Oxidase; Ureohydrolases | 2019 |
A hairpin DNA-fueled nanoflare for simultaneous illumination of two microRNAs in drug-induced nephrotoxic cells with target catalytic recycling amplification.
Topics: Biomarkers; Carbocyanines; Catalysis; DNA; Epithelial Cells; Fluoresceins; Fluorescent Dyes; Gold; Humans; Inverted Repeat Sequences; Kidney Diseases; Kidney Tubules, Proximal; Limit of Detection; Metal Nanoparticles; MicroRNAs; Nucleic Acid Amplification Techniques; Nucleic Acid Hybridization; Spectrometry, Fluorescence | 2019 |
Stem cell delivery to kidney via minimally invasive ultrasound-guided renal artery injection in mice.
Topics: Adipocytes; Animals; Cell Differentiation; Cell Proliferation; Chondrocytes; Gold; HEK293 Cells; Humans; Kidney Diseases; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Metal Nanoparticles; Mice; Osteogenesis; Photoacoustic Techniques; Renal Artery; Ultrasonography | 2020 |
Nanomedicines for Renal Management: From Imaging to Treatment.
Topics: Animals; Biocompatible Materials; Contrast Media; DNA; Glomerular Filtration Rate; Glucocorticoids; Gold; Kidney; Kidney Diseases; Magnetic Resonance Imaging; Metal Nanoparticles; Nanomedicine; Nanostructures; Positron-Emission Tomography; Tomography, X-Ray Computed | 2020 |
A pH-Responsive System Based on Fluorescence Enhanced Gold Nanoparticles for Renal Targeting Drug Delivery and Fibrosis Therapy.
Topics: Animals; Cell Line; Cobalt; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Drug Liberation; Fibrosis; Fluorescence; Glutathione; Gold; Hydrogen-Ion Concentration; Kidney; Kidney Diseases; Metal Nanoparticles; Mice, Inbred BALB C; Mononuclear Phagocyte System; Rats; Ureteral Obstruction | 2020 |
Selective Detection of Nano-Sized Diagnostic Markers Using Au-ZnO Nanorod-Based Surface-Enhanced Raman Spectroscopy (SERS) in Ureteral Obstruction Models.
Topics: Animals; Biomarkers; Collagen; Disease Models, Animal; Female; Fibrosis; Gold; Kidney; Kidney Diseases; Nanotubes; Phenylalanine; Rats, Sprague-Dawley; Spectrum Analysis, Raman; Ureteral Obstruction; Urinalysis; Zinc Oxide | 2020 |
Enhanced Ultrasound Contrast of Renal-Clearable Luminescent Gold Nanoparticles.
Topics: Animals; Contrast Media; Female; Fluorescence; Fluorescent Dyes; Gold; Kidney; Kidney Diseases; Metal Nanoparticles; Mice, Inbred BALB C; Ultrasonic Waves; Ultrasonography | 2021 |
Reduced egfr, elevated urine protein and low level of personal protective equipment compliance among artisanal small scale gold miners at Bibiani-Ghana: a cross-sectional study.
Topics: Adult; Creatinine; Cross-Sectional Studies; Ghana; Gold; Humans; Kidney Diseases; Male; Mercury; Middle Aged; Miners; Occupational Diseases; Occupational Exposure; Personal Protective Equipment; Proteinuria; Socioeconomic Factors; Workplace; Young Adult | 2017 |
Non-invasive detection of the early phase of kidney injury by photoacoustic/computed tomography imaging.
Topics: Animals; Cell Death; Cell Line; Disease Models, Animal; Gold; Humans; Kidney; Kidney Diseases; Male; Mice, Inbred BALB C; Nanoparticles; Photoacoustic Techniques; Tomography, X-Ray Computed; Ureteral Obstruction | 2018 |
How nanotechnology imaging can be used in kidney disease: an interview with Dr Mengxiao Yu.
Topics: China; Early Diagnosis; Gold; History, 21st Century; Humans; Kidney Diseases; Metal Nanoparticles; Nanomedicine; Nanotechnology; Optical Imaging; United States | 2018 |
Effects of quercetin and arginine on the nephrotoxicity and lipid peroxidation induced by gold nanoparticles in vivo.
Topics: Animals; Antioxidants; Arginine; Blood Urea Nitrogen; Creatinine; Glutathione; Gold; Kidney; Kidney Diseases; Lipid Peroxidation; Male; Malondialdehyde; Metal Nanoparticles; Quercetin; Rats, Inbred WKY; Urea; Uric Acid | 2018 |
A stimuli-responsive drug release nanoplatform for kidney-specific anti-fibrosis treatment.
Topics: Animals; Cells, Cultured; Cobalt; Drug Liberation; Fibrosis; Gold; Hydrogen-Ion Concentration; Kidney Diseases; Metal Nanoparticles; Optical Imaging; Rats | 2019 |
Sensor arrays based on nanoparticles for early detection of kidney injury by breath samples.
Topics: Animals; Biosensing Techniques; Breath Tests; Gold; Kidney; Kidney Diseases; Male; Metal Nanoparticles; Rats; Rats, Sprague-Dawley; Volatile Organic Compounds | 2014 |
Efficacy of Gold Nanoparticles against Nephrotoxicity Induced by Schistosoma mansoni Infection in Mice.
Topics: Animals; Drug Evaluation, Preclinical; Gold; Kidney Diseases; Male; Metal Nanoparticles; Mice; Schistosomiasis mansoni | 2016 |
Gold nanoparticles ameliorate acetaminophen induced hepato-renal injury in rats.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Female; Gold; Kidney; Kidney Diseases; Metal Nanoparticles; Rats; Rats, Wistar | 2017 |
[RENAL FUNCTIONAL EXPLORATION, A CRITERION FOR INDIVIDUALIZATION OF THE TREATMENT OF RHEUMATOID ARTHRITIS].
Topics: Adrenal Cortex Hormones; Antimalarials; Arthritis; Arthritis, Rheumatoid; Gold; Hematuria; Kidney Diseases; Kidney Function Tests; Leukocytes; Phenylbutazone; Proteinuria; Toxicology; Urine | 1964 |
[RHEUMATOID ARTHRITIS AND RENAL AMYLOIDOSIS].
Topics: Adolescent; Amyloidosis; Arthritis, Juvenile; Arthritis, Rheumatoid; Biopsy; Child; Gold; Humans; Kidney Diseases; Nephrotic Syndrome; Pathology; Toxicology | 1964 |
Parenteral gold in the treatment of rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Drug Administration Schedule; Drug Eruptions; Gold; Humans; Injections, Intramuscular; Kidney Diseases; Stomatitis | 1983 |
Drug-induced glomerulopathy: a selective review.
Topics: Anti-Inflammatory Agents; Captopril; Child; Gold; Humans; Kidney Diseases; Mitomycin; Mitomycins; Penicillamine; Proteinuria; Semustine | 1983 |
Gold nephropathy in rabbits using an indigenous preparation. A morphological study.
Topics: Animal Feed; Animals; Female; Glomerulonephritis; Gold; Gold Sodium Thiomalate; Kidney Diseases; Male; Proteinuria; Rabbits | 1984 |
[Drug-induced glomerular diseases].
Topics: Antihypertensive Agents; Arthritis, Rheumatoid; Gold; Humans; Kidney Diseases; Kidney Tubular Necrosis, Acute; Male; Middle Aged; Penicillamine | 1984 |
Nonspecific therapy of asthma with gold preparation and insulin.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Asthma; Aurothioglucose; Child; Female; Gold; Humans; Insulin; Kidney Diseases; Liver Diseases; Male; Middle Aged; Myocardium; Skin Physiological Phenomena; Temperature | 1981 |
[A case with gold nephropathy: X-ray energy dispersive analysis of gold deposition in renal tissue (author's transl)].
Topics: Arthritis, Rheumatoid; Female; Gold; Gold Sodium Thiomalate; Humans; Kidney; Kidney Diseases; Middle Aged; X-Ray Diffraction | 1982 |
Drug-associated nephropathy. Part I: Glomerular lesions.
Topics: Captopril; Daunorubicin; Gold; Heroin; Humans; Kidney Diseases; Kidney Glomerulus; Mercury; Microscopy, Electron; Penicillamine; Puromycin; Sulfadiazine; Trimethadione | 1980 |
Renal tubular dysfunction as a complication of gold therapy in patients with rheumatoid arthritis.
Topics: Adult; Aged; Arthritis, Rheumatoid; Basement Membrane; beta 2-Microglobulin; Female; Gold; Humans; Kidney Diseases; Kidney Tubules; Male; Middle Aged; Proteinuria | 1982 |
The relationship between D-penicillamine--induced proteinuria and prior gold nephropathy.
Topics: Adult; Aged; Arthritis, Rheumatoid; Female; Gold; HLA Antigens; Humans; Kidney Diseases; Male; Middle Aged; Penicillamine; Proteinuria | 1981 |
Toxicity of D-penicillamine in rheumatoid arthritis.
Topics: Adult; Arthritis, Rheumatoid; Dose-Response Relationship, Drug; Drug Interactions; Gold; Humans; Kidney Diseases; Myasthenia Gravis; Penicillamine; Proteinuria; Rheumatoid Factor; Time Factors | 1980 |
A rational approach to nephrotoxic drugs in the elderly.
Topics: Aged; Analgesics; Contrast Media; Drug-Related Side Effects and Adverse Reactions; Gentamicins; Gold; Humans; Kidney; Kidney Diseases; Penicillins | 1980 |
[Early diagnosis and prevention of toxic nephropathies. Discussion].
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Contrast Media; Gold; Humans; Kidney Diseases | 1994 |
The toxicity of three gold-containing compounds in laboratory animals.
Topics: Abnormalities, Drug-Induced; Animals; Animals, Laboratory; Female; Gold; Gold Sodium Thiomalate; Kidney Diseases; Neoplasms; Pregnancy; Pregnancy, Animal | 1978 |
The subacute and chronic toxicity of SK&F 36914, SK&F D-39162 and gold sodium thiomalate in rats.
Topics: Adenoma; Animals; Body Weight; Female; Gold; Gold Sodium Thiomalate; Intestinal Diseases; Kidney Diseases; Kidney Neoplasms; Male; Rats; Time Factors; Ulcer | 1978 |
Heavy metal nephropathy of rodents.
Topics: Adenoma; Animals; Gold; Gold Sodium Thiomalate; Kidney; Kidney Diseases; Kidney Neoplasms; Metals; Rats; Rodent Diseases | 1978 |
[Use of gold keratinate in the therapy of rheumatoid arthritis].
Topics: Adult; Aged; Arthritis, Rheumatoid; Blood Cells; Chemical and Drug Induced Liver Injury; Drug Eruptions; Drug Evaluation; Gastrointestinal Diseases; Gold; Hematologic Diseases; Humans; Kidney; Kidney Diseases; Liver; Middle Aged | 1975 |
Gold reactions are not more common in Sjögren's syndrome.
Topics: Adult; Aged; Arthritis, Rheumatoid; Aurothioglucose; Drug Eruptions; Female; Glossitis; Gold; Gold Sodium Thiomalate; Humans; Kidney; Kidney Diseases; Male; Middle Aged; Retrospective Studies; Sjogren's Syndrome; Stomatitis; Time Factors | 1975 |
Heavy metals and renal damage.
Topics: Bismuth; Cadmium Poisoning; Environmental Exposure; Gold; Humans; Kidney Diseases; Lead Poisoning; Mercury Poisoning; Metals; Uranium | 1979 |
Salicylate-induced enzymuria: comparison with other anti-inflammatory agents.
Topics: Acetaminophen; Acetylglucosaminidase; Adult; Anti-Inflammatory Agents; Aspirin; Gold; Hexosaminidases; Humans; Ibuprofen; Indomethacin; Kidney; Kidney Diseases; Lysosomes; Rheumatic Diseases; Salicylates | 1978 |
[Changes in kidney function in rheumatoid arthritis].
Topics: Adult; Arthritis, Rheumatoid; Female; Gold; Humans; Kidney Diseases; Male; Middle Aged; Prednisolone | 1979 |
Membranous nephropathy in patients with rheumatoid arthritis: relationship to gold therapy.
Topics: Adult; Amyloidosis; Arthritis, Rheumatoid; Female; Gold; Humans; Kidney; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Nephrosis, Lipoid | 1978 |
Spread of gold injected into the joints of healthy rabbits.
Topics: Animals; Colloids; Gold; Gold Colloid, Radioactive; Gold Sodium Thiomalate; Injections, Intra-Articular; Joints; Kidney Diseases; Kidney Tubules, Proximal; Knee Joint; Mitochondria; Mitochondria, Liver; Particle Size; Rabbits | 1976 |
[Experiences with gold in the treatment of chronic polyarthritis].
Topics: Arthritis, Rheumatoid; Chronic Disease; Gold; Humans; Kidney Diseases; Skin Manifestations | 1975 |
[Progress on diagnosis and therapy of kidney diseases complicated with rheumatoid arthritis and Sjogren's syndrome].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Gold; Humans; Kidney Diseases; Penicillamine; Prednisolone; Sjogren's Syndrome | 1992 |
Cationic colloidal gold--a novel marker for the demonstration of glomerular polyanion status in routine renal biopsies.
Topics: Adolescent; Aged; Anions; Basement Membrane; Binding Sites; Biomarkers; Child, Preschool; Female; Gold; Humans; Kidney Diseases; Kidney Glomerulus; Male; Microscopy, Electron; Middle Aged; Staining and Labeling | 1991 |
Protein A-gold immunoelectron microscopic study of amyloid fibrils, granular deposits, and fibrillar luminal aggregates in renal amyloidosis.
Topics: Amyloid; Amyloidosis; Biopsy; Cytoplasmic Granules; Gold; Humans; Kidney Diseases; Kidney Glomerulus; Microscopy, Immunoelectron; Serum Amyloid A Protein; Serum Amyloid P-Component; Substance-Related Disorders | 1990 |
[Clinicopathological study of renal disorders in patients with rheumatoid arthritis].
Topics: Adolescent; Adult; Aged; Amyloidosis; Arthritis, Rheumatoid; Female; Gold; Humans; Kidney; Kidney Diseases; Male; Middle Aged; Penicillamine | 1989 |
The natural course of gold and penicillamine nephropathy: a longterm study of 54 patients.
Topics: Adult; Arthritis, Rheumatoid; Creatinine; Female; Gold; Humans; Kidney; Kidney Diseases; Male; Middle Aged; Penicillamine; Proteinuria; Time Factors | 1989 |
The effect of continuing penicillamine and gold treatment on the course of penicillamine and gold nephropathy.
Topics: Aged; Arthritis, Rheumatoid; Biopsy; Creatinine; Female; Gold; Humans; Kidney; Kidney Diseases; Male; Middle Aged; Penicillamine; Proteinuria | 1989 |
Drug-associated glomerulopathies.
Topics: Amyloidosis; Animals; Captopril; Cyclosporins; Disease Models, Animal; Gold; Heroin Dependence; Humans; Hydrocarbons; Immune Complex Diseases; Kidney Diseases; Kidney Glomerulus; Lupus Erythematosus, Systemic; Mercury; Nephrotic Syndrome; Penicillamine; Puromycin Aminonucleoside; Serum Sickness; Solvents; Tetradecanoylphorbol Acetate | 1986 |
Elevated antigalactosyl antibody titers reflect renal injury after gold or D-penicillamine in rheumatoid arthritis.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; Antibody Formation; Antibody Specificity; Arthritis, Rheumatoid; Child; Child, Preschool; Dimercaprol; Female; Gold; Hemagglutination Tests; Humans; IgA Vasculitis; Immune Complex Diseases; Immunoglobulin G; Infant; Kidney; Kidney Diseases; Male; Middle Aged; Multiple Myeloma; Organogold Compounds; Organometallic Compounds; Penicillamine; Propanols; Sulfhydryl Compounds | 1986 |
The natural course of gold nephropathy.
Topics: Gold; Humans; Kidney Diseases; Proteinuria | 1987 |
The natural course of gold nephropathy.
Topics: Gold; Humans; Kidney Diseases | 1988 |
Evaluation of the renal injury from gold salts and nonsteroidal anti-inflammatory drugs in patients with rheumatoid arthritis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Female; Gold; Humans; Kidney Diseases; Middle Aged; Osteoarthritis | 1988 |
Immunoelectron microscopic study of glomerular lesions using a postembedding method with a protein A-gold complex.
Topics: Antigens; Complement C3; Complement C3c; Gold; Humans; Immunoglobulins; Immunologic Techniques; Kidney Diseases; Kidney Glomerulus; Microscopy, Electron; Microscopy, Fluorescence; Staphylococcal Protein A | 1987 |
Ultrastructural immuno-gold localization of immune deposits in human renal biopsies.
Topics: Complement System Proteins; Glomerulonephritis; Glomerulonephritis, IGA; Gold; Humans; Immunoglobulins; Immunohistochemistry; Kidney Diseases; Lupus Nephritis; Microscopy, Electron | 1988 |
[Toxic reactions during gold therapy].
Topics: Drug Eruptions; Gastrointestinal Diseases; Gold; Hematologic Diseases; Humans; Kidney Diseases; Methods | 1970 |
[Drug-induced nephropathies].
Topics: Colistin; Diuretics; Gold; Humans; Kanamycin; Kidney Diseases; Mercury; Methicillin; Nitrofurans; Phenindione; Phenylbutazone; Streptomycin; Sulfonamides | 1967 |
Renal disease in juvenile rheumatoid arthritis.
Topics: Adolescent; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Arthritis, Juvenile; Blood Pressure Determination; Child; Child, Preschool; Chronic Disease; Female; Gold; Hematuria; Humans; Infant; Kidney Diseases; Kidney Function Tests; Male; Proteinuria; Time Factors | 1969 |
[Side effect of aurothiomalate in the treatment of rheumatoid arthritis, with reference to renal lesions].
Topics: Adult; Animals; Arthritis, Rheumatoid; Female; Gold; Humans; Kidney; Kidney Diseases; Malates; Male; Middle Aged; Organometallic Compounds; Proteinuria; Rats; Sulfides | 1974 |
[Nephrotoxicity of antirheumatic drugs. I. Effect of nonsteroid antirheumatic drugs on urine enzymes].
Topics: Animals; Gold; Kidney; Kidney Diseases; L-Lactate Dehydrogenase; Leucyl Aminopeptidase; Phenylbutazone; Rats; Rheumatic Diseases; Sodium Salicylate | 1972 |
[Nephrotoxicity of drugs. I].
Topics: Analgesics; Anti-Bacterial Agents; Antineoplastic Agents; Bismuth; Contrast Media; Drug-Related Side Effects and Adverse Reactions; Gold; Humans; Kidney; Kidney Diseases; Mercury; Nephritis, Interstitial | 1973 |
Drug-induced nephropathies.
Topics: Animals; Arthritis, Rheumatoid; Aspirin; Colic; Complement System Proteins; Glomerular Filtration Rate; Glomerulonephritis; Gold; Hematuria; Hexosephosphates; Humans; Hypertension; Immunoglobulin G; Kidney Diseases; Nephrotic Syndrome; Penicillamine; Peptic Ulcer; Phenacetin; Prostaglandin Antagonists; Proteinuria; Rats; Urinary Tract Infections | 1973 |
[Special problems of juvenile rheumatoid arthritis].
Topics: Adrenal Cortex Hormones; Amyloidosis; Arthritis, Juvenile; Bone Development; Child; Chloroquine; Diagnosis, Differential; Eye Diseases; Female; Gold; Humans; Indomethacin; Kidney Diseases; Micrognathism | 1974 |
Gold nephropathy in rats--light and electron microscopic studies.
Topics: Animals; Disease Models, Animal; Female; Fluorescent Antibody Technique; Gold; Kidney Diseases; Kidney Glomerulus; Kidney Tubules; Male; Microscopy; Microscopy, Electron; Microscopy, Fluorescence; Necrosis; Proteinuria; Rats; Rats, Inbred Strains; Time Factors | 1971 |
[Collateral effects of gold salts in the therapy of rheumatoid arthritis].
Topics: Arthritis, Rheumatoid; Bone Marrow Diseases; Chemical and Drug Induced Liver Injury; Gold; Humans; Kidney Diseases | 1972 |
Role of mitochondria in the handling of gold by the kidney. A study by electron microscopy and electron probe microanalysis.
Topics: Animals; Electron Probe Microanalysis; Gold; Kidney; Kidney Diseases; Microscopy, Electron; Mitochondria; Rats | 1970 |
Gold therapy of rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Blood Platelet Disorders; Follow-Up Studies; Gold; Humans; Kidney Diseases; Male; Middle Aged | 1970 |
[Renal diseases in treated rheumatoid arthritis].
Topics: Adrenal Cortex Hormones; Arthritis, Rheumatoid; Gold; Humans; Kidney Diseases; Phenacetin; Proteinuria | 1970 |
[Fatal hemorrhagic diathesis following therapy with gold].
Topics: Arthritis, Rheumatoid; Chronic Disease; Drug Tolerance; Gold; Heart Diseases; Hemorrhagic Disorders; Humans; Kidney Diseases; Liver Cirrhosis | 1970 |
[Renal complications od chrysothiotherapy in progressive polyarthritis].
Topics: Arthritis, Rheumatoid; Gold; Humans; Kidney Diseases; Kidney Function Tests; Proteinuria | 1968 |
Evaluation of hemostasis with gold foil.
Topics: Animals; Gold; Hemorrhage; Hemostatics; Kidney Diseases; Rats | 1968 |